Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Berkowitz

Showing results (441-450 of 671) with videos related to

Pageof 68
Sort By:
Gynecologic Oncology|September 21, 2010
Correlates of the preoperative level of CA125 at presentation of ovarian cancerDaniel W Cramer, Allison F Vitonis, William R Welch, et al.
Gynecologic Oncology|July 13, 2010
Up-regulation of stromal versican expression in advanced stage serous ovarian cancerSue Ghosh, Lina Albitar, Richard LeBaron, et al.
Placenta. Supplement|January 1, 1981
HL-A antigen frequency distribution in patients with gestational choriocarcinoma and their husbandsR S Berkowitz, J Hornig-Rohan, S Martin-Alosco, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2007
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasionE C Koon, P C Ma, R Salgia, et al.
Journal of Ovarian Research|April 1, 2011
Differential hRad17 expression by histologic subtype of ovarian cancerJennifer L Young, E Colin Koon, Joseph Kwong, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 5, 2015
Update on the diagnosis and management of gestational trophoblastic diseaseHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
Gynecologic Oncology|August 1, 1992
Preoperative serum CA-125 levels in borderline tumors of the ovaryL W Rice, J M Lage, R S Berkowitz, et al.
Human Pathology|September 26, 2006
Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organsSadako Nishimura, Hiroshi Tsuda, Kiyoshi Ito, et al.
Gynecologic Oncology|October 22, 2008
RUNX3 protein is overexpressed in human epithelial ovarian cancerNicole S Nevadunsky, John S Barbieri, Joseph Kwong, et al.
Gynecologic Oncology|February 11, 2020
Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasiaIzildinha Maestá, Roni Nitecki, Cecilia Canedo Freitas Desmarais, et al.
Pageof 68

Showing results (441-450 of 671) with videos related to

Sort By:
Pageof 68
Gynecologic Oncology|September 21, 2010
Correlates of the preoperative level of CA125 at presentation of ovarian cancerDaniel W Cramer, Allison F Vitonis, William R Welch, et al.
Gynecologic Oncology|July 13, 2010
Up-regulation of stromal versican expression in advanced stage serous ovarian cancerSue Ghosh, Lina Albitar, Richard LeBaron, et al.
Placenta. Supplement|January 1, 1981
HL-A antigen frequency distribution in patients with gestational choriocarcinoma and their husbandsR S Berkowitz, J Hornig-Rohan, S Martin-Alosco, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2007
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasionE C Koon, P C Ma, R Salgia, et al.
Journal of Ovarian Research|April 1, 2011
Differential hRad17 expression by histologic subtype of ovarian cancerJennifer L Young, E Colin Koon, Joseph Kwong, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 5, 2015
Update on the diagnosis and management of gestational trophoblastic diseaseHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
Gynecologic Oncology|August 1, 1992
Preoperative serum CA-125 levels in borderline tumors of the ovaryL W Rice, J M Lage, R S Berkowitz, et al.
Human Pathology|September 26, 2006
Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organsSadako Nishimura, Hiroshi Tsuda, Kiyoshi Ito, et al.
Gynecologic Oncology|October 22, 2008
RUNX3 protein is overexpressed in human epithelial ovarian cancerNicole S Nevadunsky, John S Barbieri, Joseph Kwong, et al.
Gynecologic Oncology|February 11, 2020
Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasiaIzildinha Maestá, Roni Nitecki, Cecilia Canedo Freitas Desmarais, et al.
Pageof 68